A Phase 1b Study Evaluating AMG 232 Alone and in Combination With Trametinib in Acute Myeloid Leukemia
Clinical trial NCT02016729 · COMPLETED
Trial details
- NCT number
- NCT02016729
- Sponsor
- Kartos Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2017-04-19
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.